Pfizer Deal History & Licensing Activity

About Pfizer Licensing & Deal Activity

Pfizer is a large pharma company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 39 deals over the past three years, Pfizer ranks among the most acquisitive companies tracked by Ambrosia Ventures.

Key therapeutic areas of focus for Pfizer include Oncology (27 deals and trials), Solid Tumors (15 deals and trials), Metabolic (9 deals and trials), and Infectious Disease (8 deals and trials). In terms of modality, Pfizer has shown particular interest in bispecific antibodies, peptides, vaccines.

Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Pfizer and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Pfizer's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.